Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
HER-2
Email alerts
HER-2
HER-2 codon 655 polymorphism in cervical carcinogenesis
M.
Ueda
,
Y.-C.
Hung
,
Y.
Terai
,
J.
Saito
,
O.
Nunobiki
,
S.
Noda
,
M.
Ueki
International Journal of Gynecologic Cancer
Jan 2006,
16
(1)
325-328;
DOI:
10.1136/ijgc-00009577-200601000-00052
HER-2 and cancer antigen 125 evaluation in ovarian borderline tumors by immunohistochemistry and fluorescence
in situ
hybridization
J. K. R.
HEINRICH
,
F.
BÖTTCHER-LUIZ
,
L. L. A.
ANDRADE
,
S.
DAVIDSON
,
L.
BONDS
,
J.
STEPHENS
,
M.
VARELLA-GARCIA
International Journal of Gynecologic Cancer
Nov 2004,
14
(6)
1078-1085;
DOI:
10.1136/ijgc-00009577-200411000-00004
Prognostic significance of p53, Her-2, and EGFR overexpression in borderline and epithelial ovarian cancer
J. S.
NIELSEN
,
E.
JAKOBSEN
,
B.
HØLUND
,
K.
BERTELSEN
,
A.
JAKOBSEN
International Journal of Gynecologic Cancer
Nov 2004,
14
(6)
1086-1096;
DOI:
10.1136/ijgc-00009577-200411000-00005
The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers – a study of the National Cancer Institute of Canada Clinical Trials Group
B. B. Y.
Ma
,
A.
Oza
,
E.
Eisenhauer
,
G.
Stanimir
,
M.
Carey
,
W.
Chapman
,
E.
Latta
,
K.
Sidhu
,
J.
Powers
,
W.
Walsh
,
A.
Fyles
International Journal of Gynecologic Cancer
Jun 2004,
14
(4)
650-658;
DOI:
10.1136/ijgc-00009577-200407000-00013
Molecular similarities between primary peritoneal and primary ovarian carcinomas
L.-M.
Chen
,
S. D.
Yamada
,
Y.-S.
Fu
,
R. L.
Baldwin
,
B. Y.
Karlan
International Journal of Gynecologic Cancer
Oct 2003,
13
(6)
749-755;
DOI:
10.1136/ijgc-00009577-200311000-00004
HER-2/neu expression in ovarian clear cell carcinomas
H.
Iwamoto
,
H.
Fukasawa
,
T.
Honda
,
S.
Hirata
,
K.
Hoshi
International Journal of Gynecologic Cancer
Jan 2003,
13
(1)
28-31;
DOI:
10.1136/ijgc-00009577-200301000-00005
Special collections
Editor's choice
(187)
Guidelines, Recommendations and Consensus Statements
IJGC
Case Study
(17)
Cervical Cancer
(20)
Clinical Trial
(107)
Corners of the World
(23)
Endometrial Cancer
Fertility and Pregnancy
Lay summaries
(1)
Lead articles
(13)
Ovarian Cancer
(35)
Palliative Care
Perioperative Care
Preinvasive Disease
(1)
Review
(28)
Surgical Outcomes
Uterine Cancer
(16)
Video Article
(177)
Vulvar Cancer
(2)
Open access
(266)
Press releases
(4)